These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 20638287)
1. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents. Bandgar BP; Gawande SS Bioorg Med Chem; 2010 Mar; 18(5):2060-5. PubMed ID: 20138527 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors. Zhou Z; Zhuo J; Yan S; Ma L Bioorg Med Chem; 2013 Apr; 21(7):2156-62. PubMed ID: 23391365 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells. Ha YM; Park JY; Park YJ; Park D; Choi YJ; Kim JM; Lee EK; Han YK; Kim JA; Lee JY; Moon HR; Chung HY Bioorg Med Chem Lett; 2011 Apr; 21(8):2445-9. PubMed ID: 21397499 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents. Chou LC; Huang LJ; Hsu MH; Fang MC; Yang JS; Zhuang SH; Lin HY; Lee FY; Teng CM; Kuo SC Eur J Med Chem; 2010 Apr; 45(4):1395-402. PubMed ID: 20097456 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of new heterocyclic hybrids based on pyrazole and thiazolidinone scaffolds as potent inhibitors of tyrosinase. Gawande SS; Warangkar SC; Bandgar BP; Khobragade CN Bioorg Med Chem; 2013 May; 21(10):2772-7. PubMed ID: 23566759 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Insuasty B; Tigreros A; Orozco F; Quiroga J; AbonĂa R; Nogueras M; Sanchez A; Cobo J Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of new pyrazole derivatives and their anticancer evaluation. Nitulescu GM; Draghici C; Missir AV Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Alam MS Eur J Med Chem; 2011 Dec; 46(12):5763-8. PubMed ID: 22019186 [TBL] [Abstract][Full Text] [Related]
11. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives. Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity. El-Deeb IM; Lee SH Bioorg Med Chem; 2010 Jun; 18(11):3961-73. PubMed ID: 20472440 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, antiamoebic activity and cytotoxicity of new pyrazolo[3, 4-d]pyrimidine-6-one derivatives. Hayat F; Salahuddin A; Azam A J Enzyme Inhib Med Chem; 2011 Aug; 26(4):472-9. PubMed ID: 21054147 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Congiu C; Onnis V; Vesci L; Castorina M; Pisano C Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives. Zhang D; Wang G; Zhao G; Xu W; Huo L Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents. Lv PC; Wang KR; Li QS; Chen J; Sun J; Zhu HL Bioorg Med Chem; 2010 Feb; 18(3):1117-23. PubMed ID: 20056425 [TBL] [Abstract][Full Text] [Related]
18. 3,5-Diaryl-1H-pyrazole as a molecular scaffold for the synthesis of apoptosis-inducing agents. Shaw AY; Liau HH; Lu PJ; Yang CN; Lee CH; Chen JY; Xu Z; Flynn G Bioorg Med Chem; 2010 May; 18(9):3270-8. PubMed ID: 20381360 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors. Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213 [TBL] [Abstract][Full Text] [Related]
20. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]